- Stocks
- Financials
- Medico Intercon
Medico Intercon share price
NSE: MILFinancialsDrug Manufacturers - Specialty & Generic
Medico Intercon at a glance
With a market capitalisation of ₹25 Cr, it ranks 3472nd by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Financials sector; its industry is Drug Manufacturers - Specialty & Generic.
In Q4 FY26, the quarter ended 31 Mar 2026, revenue was ₹22 Cr (+5.1% year on year) and net profit −₹2 Cr (−300.9%), on a consolidated basis. Promoters held 58.51% of the company as of 30 Jun 2026.
Key numbers
- Market cap
- ₹25 CrRank 3472 on NSE
- EPS (TTM)
- −₹5.04to Q4 FY26
Returns to 22 Oct 2026
| Period | 1 day | 1 week | 1 month | 3 months | 1 year |
|---|---|---|---|---|---|
| Price change | — | — | — | — | — |
Medico Intercon quarterly results
| Quarter | Q1 FY25 | Q2 FY25 | Q3 FY25 | Q4 FY25 | Q1 FY26 | Q2 FY26 | Q3 FY26 | Q4 FY26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₹18 Cr | ₹37 Cr | ₹19 Cr | ₹21 Cr | ₹21 Cr | ₹20 Cr | ₹20 Cr | ₹22 Cr |
| Revenue YoY | −24.9% | +117.5% | +34.4% | +36.2% | +17.1% | −45.2% | +3.7% | +5.1% |
| Net profit | ₹1 Cr | ₹2 Cr | ₹1 Cr | ₹1 Cr | −₹3 Cr | −₹5 Cr | −₹2 Cr | −₹2 Cr |
| Net profit YoY | +5.9% | +87.4% | +14.7% | +12.5% | −333.3% | −378.5% | −243.6% | −300.9% |
| Net margin | 5.9% | 4.4% | 6.1% | 5.5% | −11.8% | −22.3% | −8.5% | −10.4% |
| EPS | ₹1.08 | ₹1.63 | ₹1.17 | ₹1.17 | −₹2.52 | −₹1.65 | −₹0.22 | −₹0.65 |
Medico Intercon shareholding pattern
| Holder | 31 Mar 2025 | 30 Jun 2025 | 30 Sep 2025 | 31 Dec 2025 | 31 Mar 2026 | 30 Jun 2026 |
|---|---|---|---|---|---|---|
| Promoters | 55.17% | 55.17% | 55.17% | 57.15% | 57.15% | 58.51% |
| Non-institutions | 44.83% | 44.83% | 44.83% | 42.85% | 42.85% | 41.49% |
Medico Intercon vs peers
The listed Financials companies nearest to Medico Intercon by market capitalisation.
| Company | Price | 1 day | 1 year | Market cap | P/E | ROE |
|---|---|---|---|---|---|---|
| VANICOMVani Commercial | — | — | — | ₹26 Cr | — | — |
| WILLAMAGORWilliamson Magor & Company | ₹22.50 | −1.06% | −33.4% | ₹25 Cr | — | — |
| KHANDSEKhandwala Securities | ₹16.18 | −1.34% | −25.8% | ₹25 Cr | — | — |
| PULSRINPulsar Intl | — | — | — | ₹25 Cr | — | — |
| ESARINDEsaar (India) | — | — | — | ₹25 Cr | — | — |
| MILMedico Intercon | — | — | — | ₹25 Cr | — | — |
| SMARTFINSmart Finsec | — | — | — | ₹25 Cr | — | — |
Ask anything about Medico Intercon
Pivot answers on the live chart with evidence you can check, and tests strategies against MIL's own history. Try: “Why has MIL moved over the last three months?” · “Backtest a 50-day moving-average crossover on MIL over five years” · “Compare MIL with VANICOM on margins and valuation”
Frequently asked questions about Medico Intercon
What is the market cap of Medico Intercon?
Medico Intercon's market capitalisation is ₹25 Cr (₹25 Cr) at the 22 Oct 2026 close, ranking 3472nd among the NSE companies Pivot tracks.
What were Medico Intercon's latest quarterly results?
For Q4 FY26 (quarter ended 31 Mar 2026), Medico Intercon reported revenue of ₹22 Cr, +5.1% year on year, and net profit of −₹2 Cr, −300.9% year on year.
What is the shareholding pattern of Medico Intercon?
As of 30 Jun 2026: promoters 58.51%, non-institutions 41.49%.
Who are Medico Intercon's competitors?
The listed Financials companies closest to Medico Intercon by market cap are Vani Commercial, Williamson Magor & Company, Khandwala Securities, Pulsar Intl, Esaar (India) and Smart Finsec.
Is Medico Intercon a good stock to buy?
Pivot does not give buy or sell recommendations. This page sets out Medico Intercon's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on MIL against its own history before risking money. This is analysis, not financial advice.
Sources and method
Prices: NSE daily closes to 22 Oct 2026 (returns and ratios at the 22 Oct 2026 close). Fundamentals: company filings via Moneycontrol, consolidated where available. Shareholding: exchange shareholding-pattern filings. The 52-week range uses intraday highs and lows; the chart marks closing prices. P/E is the last close over trailing twelve-month EPS. Market-cap rank is among the 4,183 NSE companies Pivot tracks; SEBI's bands call the top 100 large-cap and the next 150 mid-cap. Figures marked “—” are not available rather than zero. This is analysis, not financial advice.
More: all Financials stocks · companies starting with M · all NSE stocks · this page as text